Browsing Tag
Que Dallara
4 posts
Is MiniMed (Nasdaq: MMED) worth watching after its IPO slide and before June earnings?
MiniMed (Nasdaq: MMED) is down from its IPO price. Read what June earnings, new product launches, and analyst targets could mean next.
MiniMed IPO: Medtronic (NYSE: MDT) to separate diabetes business with Nasdaq filing under MMED
Medtronic files IPO for MiniMed, its diabetes business. Find out what the Nasdaq listing means for the company’s strategy, margins, and the diabetes tech sector.
Medtronic to spin off diabetes business: What the 2025 separation means for investors and the future of insulin technology
Find out how Medtronic’s Diabetes spin-off will reshape its business strategy and create a standalone insulin tech leader focused on innovation.
Medtronic to acquire South Korean medical device company EOFlow
Ireland-based healthcare technology company Medtronic has announced an agreement to acquire EOFlow, a South Korean medical device company,…